Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/28/2012

zures and C. difficile-associated diarrhea (CDAD); for full U.S. prescribing information on our products, please download the package inserts at http://www.viropharma.com/Products.aspx; the prescribing information for other countries can be found at www.viropharma.com

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Disclosure Notice Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events. Forward looking statements in this press release include our financial guidance for 2012, our belief that Vancocin meets the requirements for, and thus received, three years of exclusivity, ability to continue to successfully commercialize our products in the United States and Europe, our ability to complete manufacturing scale up procedures, and receive regulatory approvals in the time frames anticipated, our ability to manufacture specified quantities of Cinryze utilizing the existing manufacturing process or additional manufacturing procedures; our ability to pursue regulatory approvals in additional territories; and our ability to conduct additional studies in the timeframes we anticipate.

Our actual results may vary depending on a variety of factors, including:

  • the development of competitive generic versions of oral Vancocin;
  • our ability to receive regulatory approval for the use of Cinryze for additional indications and formulations and in additional territories in the
    '/>"/>

  • SOURCE ViroPharma Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related biology technology :

    1. ViroPharma to Present at Three September Healthcare Conferences
    2. ViroPharma to Present at Three October Healthcare Conferences
    3. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
    4. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
    5. ViroPharma to Present at Three November Healthcare Conferences
    6. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
    7. ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes
    8. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
    9. ViroPharma Incorporated Reports First Quarter 2009 Financial Results
    10. ViroPharma Incorporated Honored by the National Organization for Rare Disorders
    11. ViroPharma to Present at Two June Healthcare Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... the University of Delaware, is known worldwide for ... environmental sustainability and electronics. , His early academic ... well-defined, crystalline structure. At the atomic scale, their ... can separate molecules with size differences of merely ... nanometer), making them useful to the chemical and ...
    (Date:7/24/2014)... California (PRWEB) July 24, 2014 ... to advances in modeling lithium-ion battery storage capacity. ... benefit from a theoretical model created at ... University that predicts how carbon components will ... energy storage emphasizes the urgent need for higher-performance ...
    (Date:7/24/2014)... 2014 Deep Research Report on Global ... and in-depth research report on Potassium Sulphate ... information, including its definition, classification, application, and industry ... the international market analysis, including China’s domestic market ... environment & economic situation analysis, the influence of ...
    (Date:7/24/2014)... 24, 2014 The first part of ... in First in Human Studies” will cover comprehensive clinical ... decisions. , With increasing R&D costs and declining industry ... to maximize the knowledge collected in early Phase I/IIa ... success in late stage development. , Next, the presenters ...
    Breaking Biology Technology:University of Delaware researcher describes new approach for creating organic zeolites 2Getting More Life out of Lithium-ion Batteries 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
    ... API Software, Inc. announced today that ... than 300,000 people located in Ridgewood, N.J., has successfully ... scheduling applications. , ,Payrollmation automates time and ... company says that this will improve employee morale and ...
    ... for $22,000 in awards this Friday as part of ... Competition . Fourteen teams of aspiring student entrepreneurs, representing ... plans for technology-based businesses to a panel of experts ... System, this competition is the only activity on campus ...
    ... that China represents phenomenal opportunities for Wisconsin companies. ... in China and other parts of the world must ... technology. , ,On the mission to China, ... efforts of both businesses and the Chinese government to ...
    Cached Biology Technology:Valley Hospital implements API's solution for 3,500 employees 2Students compete for $22,000 in Tech Business Plan Competition 2Students compete for $22,000 in Tech Business Plan Competition 3Protecting your intellectual property in overseas markets 2
    (Date:7/24/2014)... covered central Africa in mid-July 2014, as the annual ... which indicate areas of increased temperatures, are heavily sprinkled ... of the Congo (northeast), and Zambia (southeast). Thick gray ... some areas, especially in the Democratic Republic of the ... , The fire season is an annual event in ...
    (Date:7/24/2014)... German . The ... threats to health, and to provide life-long memory that ... underlying immunologic memory, however, has remained elusive. Since 2001, ... hypothesis that the persistence of immune memory arises from ... now, there was no conclusive evidence, largely because experiments ...
    (Date:7/23/2014)... or neglected early in life are at risk ... In a new study, scientists have found that ... has implications for children,s long-term development. Previous studies ... and genetics interacted with that child,s experiences in ... In the new study, researchers were able to ...
    Breaking Biology News(10 mins):Experiments prove 'stemness' of individual immune memory cells 2Experiments prove 'stemness' of individual immune memory cells 3Stress tied to change in children's gene expression related to emotion regulation, physical health 2Stress tied to change in children's gene expression related to emotion regulation, physical health 3
    ... A major study calling for levels of obesity among South ... the University of Leicester. A team from the ... the case for the point at which South Asians should ... has been published in PLoS One , a journal ...
    ... a tasteless, colorless and odorless gas, is not only a ... beings. Found in the exhaust of vehicles and generators, CO ... lethal, poisoning the nervous system and heart. Now, ... University,s Department of Geography and the Human Environment has discovered ...
    ... the American Society for Microbiology and Chair of the ... has been named the 2012 Laureate for North ... Created in 1998, the L,ORAL-UNESCO Awards recognize five ... Each year, a Laureate is chosen from each of ...
    Cached Biology News:New research calls for lower limit to be set for South Asian obesity level 2Carbon monoxide -- the silent calmer? 2Bonnie Bassler chosen North American Laureate for L’OREAL-UNESCO award 2
    Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
    Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
    Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
    Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region...
    Biology Products: